Literature DB >> 8990055

Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria.

J Montplaisir1, S Boucher, G Poirier, G Lavigne, O Lapierre, P Lespérance.   

Abstract

One hundred thirty-three cases of restless legs syndrome (RLS), diagnosed with criteria recently formulated by an international study group, were studied by questionnaire and with all-night polysomnographic recordings. Results show that RLS starts at a mean age of 27.2 years and before age 20 in 38.3% of patients. Symptoms often appear in one leg only and also involve upper limbs in about half of all cases. Most patients (94%) report sleep-onset insomnia or numerous nocturnal awakenings due to RLS symptoms. A strong relationship was found between these complaints and polysomnographic findings; increasing sleep latency and number of awakenings and decreasing sleep efficiency were associated with worsening symptoms. Periodic leg movements in sleep (index > 5 movements/h sleep) were found in 80.2% of patients. This study shows that this percentage is increased when 2 recording nights are considered (most severe score). Eighty patients of 127 (63%) reported the presence of RLS in at least one of their first-degree relatives. In these families, 221 of 568 first-degree relatives (39%) were reported by the patients to be affected with RLS.

Entities:  

Mesh:

Year:  1997        PMID: 8990055     DOI: 10.1002/mds.870120111

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  163 in total

Review 1.  Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors:  Svenja Happe; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Restless legs syndrome: pathophysiology, clinical presentation and management.

Authors:  Claudia Trenkwalder; Walter Paulus
Journal:  Nat Rev Neurol       Date:  2010-06       Impact factor: 42.937

3.  Restless legs syndrome: diagnostic assessment and the advantages and risks of dopaminergic treatment.

Authors:  Birgit Högl; Walter Paulus; Peter Clarenbach; Claudia Trenkwalder
Journal:  J Neurol       Date:  2006-08       Impact factor: 4.849

Review 4.  Iron for restless legs syndrome.

Authors:  Lynn M Trotti; Srinivas Bhadriraju; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

5.  Projections of diencephalic dopamine neurons into the spinal cord in mice.

Authors:  S Qu; W G Ondo; X Zhang; W J Xie; T H Pan; W D Le
Journal:  Exp Brain Res       Date:  2005-07-26       Impact factor: 1.972

6.  Nature and variants of idiopathic restless legs syndrome: observations from 152 patients referred to secondary care in the UK.

Authors:  R Holmes; S Tluk; V Metta; P Patel; R Rao; A Williams; K R Chaudhuri
Journal:  J Neural Transm (Vienna)       Date:  2007-01-22       Impact factor: 3.575

Review 7.  Restless legs syndrome in children.

Authors:  Murali Maheswaran; Clete A Kushida
Journal:  MedGenMed       Date:  2006-06-20

Review 8.  Caenorhabditis elegans and its applicability to studies on restless legs syndrome.

Authors:  Pan Chen; Omamuyovwi Meashack Ijomone; Kun He Lee; Michael Aschner
Journal:  Adv Pharmacol       Date:  2019-03-14

9.  Impact of restless legs syndrome in patients with inflammatory bowel disease on sleep, fatigue, and quality of life.

Authors:  Katharina A Schindlbeck; Janek Becker; Felix Berger; Arne Mehl; Charlotte Rewitzer; Sarah Geffe; Peter M Koch; Jan C Preiß; Britta Siegmund; Jochen Maul; Frank Marzinzik
Journal:  Int J Colorectal Dis       Date:  2016-10-18       Impact factor: 2.571

10.  Restless Legs Syndrome and Depression: Effect Mediation by Disturbed Sleep and Periodic Limb Movements.

Authors:  Brian B Koo; Terri Blackwell; Hochang B Lee; Katie L Stone; Elan D Louis; Susan Redline
Journal:  Am J Geriatr Psychiatry       Date:  2016-04-27       Impact factor: 4.105

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.